Page last updated: 2024-09-04

cinacalcet and Vascular Diseases

cinacalcet has been researched along with Vascular Diseases in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (62.50)	29.6817
2010's	3 (37.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fernández Giráldez, ED	1
Yokoyama, K	1
Block, GA; Chertow, GM; Csiky, B; Dehmel, B; Downey, G; Floege, J; Goodman, WG; Lopez, N; Moustafa, M; Naso, A; Nossuli, K; Raggi, P; Torres, PU	1
Taniguchi, M	1
Koiwa, F; Maruta, Y	1
Choukroun, G; Esper, NE; Fournier, A; Harbouche, L; Massy, Z; Monge, M; Morinière, P; Shahapuni, I	1
Cunningham, J	1
Arias, M; de Francisco, AL; Palomar, R; Piñera, C	1

Reviews

6 review(s) available for cinacalcet and Vascular Diseases

Article	Year
[Clinical advances in vascular calcification]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2008, Volume: 28 Suppl 5 Topics: Aged; Animals; Atherosclerosis; Calcinosis; Chronic Disease; Cinacalcet; Coronary Artery Disease; Diabetes Complications; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Diseases; Mice; Mice, Knockout; Multicenter Studies as Topic; Naphthalenes; Polyamines; Randomized Controlled Trials as Topic; Renal Artery; Sevelamer; Tomography, Spiral Computed; Tomography, X-Ray Computed; Vascular Diseases	2008
[Chronic kidney disease (CKD) and bone. Vascular calcification in CKD]. Clinical calcium, 2009, Volume: 19, Issue:4 Topics: Animals; Calcinosis; Calcium; Chelating Agents; Chronic Disease; Cinacalcet; Diphosphonates; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperphosphatemia; Kidney Diseases; Naphthalenes; Phosphates; Polyamines; Prognosis; Randomized Controlled Trials as Topic; Rats; Sevelamer; Vascular Diseases	2009
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). The impact of CKD-MBD on mortality]. Clinical calcium, 2010, Volume: 20, Issue:7 Topics: Bone Diseases, Metabolic; Calcinosis; Calcium; Chronic Disease; Cinacalcet; Humans; Kidney Diseases; Naphthalenes; Parathyroid Hormone; Phosphorus; Polyamines; Prognosis; Risk; Sevelamer; Survival Rate; Vascular Diseases; Vitamin D	2010
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of cinacalcet in the treatment of CKD-MBD]. Clinical calcium, 2010, Volume: 20, Issue:7 Topics: Bone Diseases, Metabolic; Calcinosis; Calcium; Chronic Disease; Cinacalcet; Clinical Trials as Topic; Drug Therapy, Combination; Fractures, Bone; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Naphthalenes; Parathyroid Hormone; Phosphorus; Vascular Diseases; Vitamin D	2010
[Management of secondary hyperparathyroidism]. Clinical calcium, 2005, Volume: 15 Suppl 1 Topics: Aniline Compounds; Calcinosis; Calcium; Cinacalcet; Clinical Trials as Topic; Drug Design; Drug Therapy, Combination; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phenethylamines; Phosphorus; Polyamines; Practice Guidelines as Topic; Propylamines; Receptors, Calcium-Sensing; Sevelamer; Vascular Diseases; Vitamin D	2005
Impact of treatment with calcimimetics on hyperparathyroidism and vascular mineralization. Journal of the American Society of Nephrology : JASN, 2006, Volume: 17, Issue:12 Suppl 3 Topics: Calcinosis; Calcium; Chronic Disease; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Naphthalenes; Vascular Diseases	2006

Trials

1 trial(s) available for cinacalcet and Vascular Diseases

Article	Year
Study design and subject baseline characteristics in the ADVANCE Study: effects of cinacalcet on vascular calcification in haemodialysis patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010, Volume: 25, Issue:6 Topics: Aged; Calcinosis; Cinacalcet; Coronary Artery Disease; Disease Progression; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Renal Dialysis; Vascular Diseases; Vitamin D	2010

Article

Year

Study design and subject baseline characteristics in the ADVANCE Study: effects of cinacalcet on vascular calcification in haemodialysis patients.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010, Volume: 25, Issue:6

Topics: Aged; Calcinosis; Cinacalcet; Coronary Artery Disease; Disease Progression; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Renal Dialysis; Vascular Diseases; Vitamin D

2010

Other Studies

1 other study(ies) available for cinacalcet and Vascular Diseases

Article	Year
Cinacalcet and vascular calcifications induced by calcitriol. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:2 Topics: Animals; Calcinosis; Calcitriol; Cinacalcet; Naphthalenes; Rats; Treatment Failure; Vascular Diseases	2006